Time to Treat First Acute Attack of Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseYoung Nam Kwon, Sung Min Kim, Jinseok Park et al.|JAMA Neurology|2024Cited by 26
Evaluating Rituximab Failure Rates in Neuromyelitis Optica Spectrum Disorder: A Nationwide Real-World Study From South KoreaSu‐Hyun Kim, Ho Jin Kim, Eun Bin Cho et al.|Journal of Clinical Neurology|2025Cited by 11
Outcomes of immunosuppressive therapy discontinuation in patients with myelin oligodendrocyte glycoprotein antibody-associated diseaseYou‐Ri Kang, Seung Ho Choo, Hyung-Soo Lee et al.|Multiple Sclerosis Journal|2025Cited by 5
Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective StudyHee Jo Han, Ha Young Shin, Jong Kuk Kim et al.|Journal of Korean Medical Science|2024Cited by 2